CatalYm to Present Primary Results From Phase 2 Neoadjuvant Bladder Cancer Trial in Late-breaking Oral Presentation at ESMO

businesswire

CatalYm to Present Primary Results From Phase 2 Neoadjuvant Bladder Cancer Trial in Late-breaking Oral Presentation at ESMO – NEWSnet – News… as it used to be

More Press Releases

May 20, 2026

Epsilon Announces 2026 AGM Results

May 20, 2026

ThredUp to Participate in TD Cowen and William Blair Investor Conferences

May 20, 2026

Banzai International, Inc. Expands Market Reach, Announces Strategic Alliance with Ingram Micro

May 20, 2026

CatalYm to Present Primary Results From Phase 2 Neoadjuvant Bladder Cancer Trial in Late-breaking Oral Presentation at ESMO

Epsilon Announces 2026 AGM Results

ThredUp to Participate in TD Cowen and William Blair Investor Conferences

Banzai International, Inc. Expands Market Reach, Announces Strategic Alliance with Ingram Micro

Osisko Development Announces Proposed Offering of US$275.0 Million Aggregate Principal Amount of Convertible Senior Notes